Medical Aesthetics Market

Medical Aesthetics Market - Distribution by Type of Product and / or Device Offered (Botox, Dermal Fillers, Chemical Peels, Body Contouring, Gluteal Implants, Hair Removal, Breast Implants and Other Products and / or Devices), Type of Procedure (Non Invasive, Minimally Invasive and Invasive), End User (Hospitals, Clinics / Med Spas and Dermatology / Cosmetology Centers, and Other end users), Gender (Male and Female), Distribution Channel (Direct Distribution and Indirect Distribution), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    45

  • Pages
    341

  • View Count
    9255

Table Of Contents

1. PREFACE
1.1. Introduction
1.2. Project Objectives
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations

2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates

3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry

3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION
5.1. Chapter Overview
5.2. Concept of Medical Aesthetics
5.3. Evolution of Medical Aesthetics

5.4. Types of Medical Aesthetic Procedures
5.4.1. Non-invasive Procedures
5.4.1.1. Facial Aesthetics
5.4.1.1.1. Botulinum Toxin
5.4.1.1.2. Dermal Fillers
5.4.1.1.3. Chemical Peels
5.4.1.1.4. Microdermabrasion
5.4.1.1.5. Microneedling
5.4.1.1.6. Thread Lift

5.4.1.2. Body Contouring
5.4.1.3. Hair Removal
5.4.1.3.1. Intense Pulse Light Hair Removal
5.4.1.3.2. Laser Hair Removal

5.4.1.4. Tattoo Removal
5.4.1.5. Nail Treatment
5.4.1.6. Eyelash Treatment
5.4.1.7. Permanent Make-up

5.4.2. Invasive Procedures
5.4.2.1. Breast Surgery
5.4.2.2. Gluteal Implants
5.4.2.3. Facial Surgery
5.4.2.4. Liposuction
5.4.2.5. Cosmetic Gynecology

5.5. Advantages of Medical Aesthetics
5.6. Side Effects of Medical Aesthetics
5.7. Key Growth Drivers

5.8. Emerging Technologies in Medical Aesthetics
5.8.1. Virtual Reality in Medical Aesthetics
5.8.2. Augmented Reality in Medical Aesthetics
5.8.3. Artificial Intelligence in Medical Aesthetics
5.8.4. Telemedicine in Medical Aesthetics

5.9. Key Challenges of Medical Aesthetics
5.10. Future Perspectives

6. MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Medical Aesthetic Companies: Overall Market Landscape
6.2.1. Analysis by Year of Establishment
6.2.2. Analysis by Company Size
6.2.3. Analysis by Location of Headquarters (Region)
6.2.4. Analysis by Location of Headquarters (Country)
6.2.5. Analysis by Year of Establishment and Location of Headquarters (Region)
6.2.6. Analysis by Company Size and Location of Headquarters (Region)
6.2.7. Analysis by Type of Offering
6.2.8. Analysis by Type of Products and / or Devices Offered
6.2.9. Analysis by Type of Facial Aesthetic Products and / or Devices Offered
6.2.10. Analysis by Type of Body Contouring Products and / or Devices Offered
6.2.11. Analysis by Type of Hair Removal Devices Offered
6.2.12. Analysis by Type of Breast Aesthetic Products and / or Devices Offered
6.2.13. Analysis by Application Area
6.2.14. Analysis by Type of Procedure
6.2.15. Analysis by End-user
6.2.16. Analysis by Type of Products and / or Devices Offered and Location of Headquarters (Region)
6.2.17. Analysis by Type of Procedure and Location of Headquarters (Region)

7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Detailed Company Profiles of Key Players

7.2.1. Companies Headquartered in North America
7.2.1.1. Allergan Aesthetics
7.2.1.1.1. Company Overview
7.2.1.1.2. Financial Information
7.2.1.1.3. Medical Aesthetics Portfolio
7.2.1.1.4. Recent Developments and Future Outlook

7.2.1.2. Candela Medical
7.2.1.2.1. Company Overview
7.2.1.2.2. Medical Aesthetics Portfolio
7.2.1.2.3. Recent Developments and Future Outlook

7.2.1.3. Cynosure
7.2.1.3.1. Company Overview
7.2.1.3.2. Medical Aesthetics Portfolio
7.2.1.3.3. Recent Developments and Future Outlook

7.2.1.4. Lutronic
7.2.1.4.1. Company Overview
7.2.1.4.2. Medical Aesthetics Portfolio
7.2.1.4.3. Recent Developments and Future Outlook

7.2.1.5. Mentor
7.2.1.5.1. Company Overview
7.2.1.5.2. Medical Aesthetics Portfolio
7.2.1.5.3. Recent Developments and Future Outlook

7.2.2. Companies Headquartered in Europe
7.2.2.1. BTL Aesthetics
7.2.2.1.1. Company Overview
7.2.2.1.2. Medical Aesthetics Portfolio
7.2.2.1.3. Recent Developments and Future Outlook

7.2.2.2. Croma Pharma
7.2.2.2.1. Company Overview
7.2.2.2.2. Financial Information
7.2.2.2.3. Medical Aesthetics Portfolio
7.2.2.2.4. Recent Developments and Future Outlook

7.2.2.3. Galderma
7.2.2.3.1. Company Overview
7.2.2.3.2. Financial Information
7.2.2.3.3. Medical Aesthetics Portfolio
7.2.2.3.4. Recent Developments and Future Outlook

7.2.2.4. IBSA
7.2.2.4.1. Company Overview
7.2.2.4.2. Medical Aesthetics Portfolio
7.2.2.4.3. Recent Developments and Future Outlook

7.2.2.5. Sinclair Pharma
7.2.2.5.1. Company Overview
7.2.2.5.2. Medical Aesthetics Portfolio
7.2.2.5.3. Recent Developments and Future Outlook

7.2.3. Companies Headquartered in Asia-Pacific and Rest of the World
7.2.3.1. Classys
7.2.3.1.1. Company Overview
7.2.3.1.2. Financial Information
7.2.3.1.3. Medical Aesthetics Portfolio
7.2.3.1.4. Recent Developments and Future Outlook

7.2.3.2. Daeyang Medical
7.2.3.2.1. Company Overview
7.2.3.2.2. Medical Aesthetics Portfolio
7.2.3.2.3. Recent Developments and Future Outlook

7.2.3.3. Establishment Labs
7.2.3.3.1. Company Overview
7.2.3.3.2. Financial Information
7.2.3.3.3. Medical Aesthetics Portfolio
7.2.3.3.4. Recent Developments and Future Outlook

7.2.3.4. Lumenis
7.2.3.4.1. Company Overview
7.2.3.4.2. Medical Aesthetics Portfolio
7.2.3.4.3. Recent Developments and Future Outlook

7.2.3.5. Shanghai Haohai Biological Technology
7.2.3.5.1. Company Overview
7.2.3.5.2. Financial Information
7.2.3.5.3. Medical Aesthetics Portfolio
7.2.3.5.4. Recent Developments and Future Outlook

7.3. Short Profiles of Other Prominent Players
7.3.1. ADSS
7.3.1.1. Company Overview
7.3.1.2. Medical Aesthetics Portfolio

7.3.2. Astiland
7.3.2.1. Company Overview
7.3.2.2. Medical Aesthetics Portfolio

7.3.3. Beijing Kes Biological Technology
7.3.3.1. Company Overview
7.3.3.2. Medical Aesthetics Portfolio

7.3.4. Guangzhou Itech Aesthetics 7.3.4.1.Company Overview
7.3.4.2. Medical Aesthetics Portfolio

7.3.5. MedicalZone
7.3.5.1. Company Overview
7.3.5.2. Medical Aesthetics Portfolio

7.3.6. Sanhe Medical
7.3.6.1. Company Overview
7.3.6.2. Medical Aesthetics Portfolio

7.3.7. Sincoheren
7.3.7.1. Company Overview
7.3.7.2. Medical Aesthetics Portfolio

7.3.8. Skin Tech Pharma
7.3.8.1. Company Overview
7.3.8.2. Medical Aesthetics Portfolio

7.3.9. Wontech
7.3.9.1. Company Overview
7.3.9.2. Medical Aesthetics Portfolio

7.3.10. Zesay Beauty
7.3.10.1. Company Overview
7.3.10.2. Medical Aesthetics Portfolio

8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Key Assumptions and Parameters
8.3. Methodology
8.4. Medical Aesthetics: Company Competitiveness Analysis
8.4.1. Companies based in North America
8.4.2. Companies based in Europe
8.4.3 Companies based in Asia-Pacific and Rest of the World

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Medical Aesthetics: Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Focus Area
9.3.5. Most Active Players: Analysis by Number of Partnerships

9.4. Analysis by Geography
9.4.1. Local and International Agreements
9.4.2. Intracontinental and Intercontinental Agreements

10. FUNDING AND INVESTMENTS
10.1. Chapter Overview
10.2. Funding Models
10.3. Medical Aesthetics: Funding and Investments
10.3.1. Analysis by Year of Funding
10.3.2. Analysis by Amount Invested
10.3.3. Analysis by Type of Funding
10.3.4. Analysis by Year and Type of Funding
10.3.5. Analysis by Type of Funding and Amount Invested
10.3.6. Analysis by Geography

10.3.7. Most Active Players
10.3.7.1. Analysis by Number of Funding Instances
10.3.7.2. Analysis by Amount Raised

10.3.8. Leading Investors: Analysis by Number of Funding Instances
10.3.9. Analysis by Company Size and Amount Invested

10.4. Concluding Remarks

11. DELT ANALYSIS
11.1. Chapter Overview
11.2. Methodology
11.3. Key Parameters
11.3.1. Demographical Factors
11.3.2. Environmental Factors
11.3.3. Legal Factors
11.3.4. Technological Factors

11.4. Medical Aesthetics: DELT Analysis
11.4.1. Allergan Aesthetics
11.4.2. Candela
11.4.3. Cutera
11.4.4. Biotechitalia
11.4.5. Sinclair Pharma
11.4.6. Merz Pharma
11.4.7. Dermosistemi
11.4.8. Alma Lasers
11.4.9. Bison Medical
11.5. Conclusion

12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
12.1. Chapter Overview
12.2. Market Drivers
12.3. Market Restraints
12.4. Market Opportunities
12.5. Market Challenges
12.6. Conclusion

13. GLOBAL MEDICAL AESTHETICS MARKET
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Global Medical Aesthetics Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
13.3.1. Scenario Analysis
13.3.1.1. Conservative Scenario Analysis
13.3.1.2. Optimistic Scenario Analysis

13.4. Key Market Segmentations
13.5. Dynamic Dashboards

14. MEDICAL AESTHETICS MARKET, BY TYPE OF PRODUCT AND / OR DEVICE OFFERED
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Medical Aesthetics Market: Distribution by Type of Product and / or Device Offered, 2018, 2023 and 2035
14.3.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.4. Body Contouring: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.5. Hair Removal: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.6. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.7. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
14.3.8. Other Products and / or Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

14.4. Data Triangulation and Validation

15. MEDICAL AESTHETICS MARKET, BY TYPE OF PROCEDURE
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Medical Aesthetics Market: Distribution by Type of Procedure, 2018, 2023 and 2035
15.3.1. Non-invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.3.2. Minimally Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
15.3.3. Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

15.4. Data Triangulation and Validation

16. MEDICAL AESTHETICS MARKET, BY END-USER
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Medical Aesthetics Market: Distribution by End-user, 2018, 2023 and 2035
16.3.1. Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.2.. Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
16.3.3. Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

16.4. Data Triangulation and Validation

17. MEDICAL AESTHETICS MARKET, BY GENDER
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Medical Aesthetics Market: Distribution by Gender, 2018, 2023 and 2035
17.3.1. Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.3.2. Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

17.4. Data Triangulation and Validation

18. MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Medical Aesthetics Market, by Distribution Channel, 2018, 2023 and 2035
18.3.1. Direct Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.3.2. Indirect Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

18.4. Data Triangulation and Validation

19. MEDICAL AESTEHTICS MARKET, BY KEY GEOGRAPHICAL REGION
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Medical Aesthetics Market: Distribution by Key Geographical Regions, 2019, 2023 and 2035
19.3.1. North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.1.1. US: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.1.2. Canada: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.1.3. Mexico: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2. Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.1. UK: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.2. Germany: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.3. France: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.4. Italy: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.5. Spain: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.2.5. Rest of the Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3. Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.1. China: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.2. South Korea Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.3. Japan: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.3.4. India: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)

19.3.4. Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4.1. Turkey: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4.2. Iran: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.4.3. Rest of the Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)

19.3.5. Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5.1. Brazil: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5.2. Argentina: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.3.5.3. Rest of the Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)

19.4. Data Triangulation and Validation

20. MEDICAL AESTHETICS PRODUCTS MARKET
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Global Medical Aesthetics Products Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1. Medical Aesthetics Products Market, by Type of Product Offered, 2018, 2023 and 2035
20.3.1.1. Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.2. Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.3. Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.4. Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.1.5. Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

20.4.1. Medical Aesthetics Products Market, by Key Geographical Regions, 2018, 2023 and 2035
20.4.1.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.4. Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4.1.5. Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)

20.5. Data Triangulation and Validation

21. EXECUTIVE INSIGHTS

22. CONCLUSION

23. APPENDIX 1: TABULATED DATA

24. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Research Methodology: Research Assumptions
Figure 2.2 Research Methodology: Project Methodology
Figure 2.3 Research Methodology: Forecast Methodology
Figure 2.4 Research Methodology: Robust Quality Control
Figure 2.5 Research Methodology: Key Market Segmentations
Figure 4.1 Executive Summary: Market Landscape
Figure 4.2 Executive Summary: Partnerships and Collaborations
Figure 4.3 Executive Summary: Funding and Investments
Figure 4.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 5.1 Medical Aesthetics: Non-invasive Procedures
Figure 5.2 Medical Aesthetics: Invasive Procedures
Figure 5.3 Advantages of Medical Aesthetics
Figure 5.4 Side Effects of Medical Aesthetics
Figure 6.1 Medical Aesthetic Companies: Distribution by Year of Establishment
Figure 6.2 Medical Aesthetic Companies: Distribution by Company Size
Figure 6.3 Medical Aesthetic Companies: Distribution by Location of Headquarters (Region)
Figure 6.4 Medical Aesthetic Companies: Distribution by Location of Headquarters (Country)
Figure 6.5 Medical Aesthetic Companies: Distribution by Year of Establishment and Location of Headquarters (Region)
Figure 6.6 Medical Aesthetic Companies: Distribution by Company Size and Location of Headquarters (Region)
Figure 6.7 Medical Aesthetic Companies: Distribution by Type of Offering
Figure 6.8 Medical Aesthetic Companies: Distribution by Type of Products and / or Devices Offered
Figure 6.9 Medical Aesthetic Companies: Distribution by Type of Facial Aesthetic Products and / or Devices Offered
Figure 6.10 Medical Aesthetic Companies: Distribution by Type of Body Contouring Products and / or Devices Offered
Figure 6.11 Medical Aesthetic Companies: Distribution by Type of Hair Removal Devices Offered
Figure 6.12 Medical Aesthetic Companies: Distribution by Type of Breast Aesthetic Products and / or Devices Offered
Figure 6.13 Medical Aesthetic Companies: Distribution by Application Area
Figure 6.14 Medical Aesthetic Companies: Distribution by Type of Procedure
Figure 6.15 Medical Aesthetic Companies: Distribution by End-user
Figure 6.16 Medical Aesthetic Companies: Distribution by Type of Products and / or Devices Offered and Location of Headquarters (Region)
Figure 6.17 Medical Aesthetic Companies: Type of Procedure and Distribution by Location of Headquarters (Region)
Figure 7.1 Allergan Aesthetics: Annual Revenues, FY 2020-H1 FY 2023 (USD Billion)
Figure 7.2 Croma Pharma: Annual Revenues, FY 2021-H1 FY 2022 (EUR Million)
Figure 7.3 Galderma: Annual Revenues, FY 2020-FY H1 2023 (USD Billion)
Figure 7.4 Classys: Annual Revenues, FY 2020-H1 FY 2023 (KRW Million)
Figure 7.5 Establishment Labs: Annual Revenues, FY 2019-H1 FY 2023 (USD Million)
Figure 7.6 Shanghai Haohai Biological Technology: Annual Revenues, FY 2019-H1 FY 2023 (RMB Million)
Figure 8.1 Company Competitiveness Analysis: Companies based in North America (Peer Group I)
Figure 8.2 Company Competitiveness Analysis: Companies based in North America (Peer Group II)
Figure 8.3 Company Competitiveness Analysis: Companies based in Europe (Peer Group I)
Figure 8.4 Company Competitiveness Analysis: Companies based in Europe (Peer Group II)
Figure 8.5 Company Competitiveness Analysis: Companies based in Asia-Pacific and Rest of the World (Peer Group I)
Figure 8.6 Company Competitiveness Analysis: Companies based in Asia-Pacific and Rest of the World (Peer Group II)
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2023
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2018-2023
Figure 9.4 Partnerships and Collaborations: Distribution by Focus Area
Figure 9.5 Most Active Players: Distribution by Number of Partnerships
Figure 9.6 Partnerships and Collaborations: Local and International Agreements
Figure 9.7 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1 Funding and Investments: Cumulative Year-wise Trend, 2018-2023
Figure 10.2 Funding and Investments: Distribution by Amount Invested (USD Million)
Figure 10.3 Funding and Investments: Distribution by Type of Funding
Figure 10.4 Funding and Investments: Distribution by Year and Type of Funding, 2018-2023
Figure 10.5 Funding and Investments: Distribution by Type of Funding and Amount Invested (USD Million)
Figure 10.6 Funding and Investments: Distribution by Geography (Region)
Figure 10.7 Funding and Investments: Distribution by Geography (Country)
Figure 10.8 Most Active Players: Distribution by Number of Funding Instances
Figure 10.9 Most Active Players: Distribution by Amount Raised (USD Million)
Figure 10.10 Leading Investors: Distribution by Number of Funding Instances
Figure 10.11 Funding and Investments: Distribution by Company Size and Amount Invested
Figure 10.12 Funding and Investments Summary, 2018-2023 (USD Million)
Figure 11.1 DELT Analysis: Impact of Internal and External Factors
Figure 11.2 DELT Analysis: Key Parameters
Figure 11.3 DELT Analysis: Allergan Aesthetics
Figure 11.4 DELT Analysis: Candela
Figure 11.5 DELT Analysis: Cutera
Figure 11.6 DELT Analysis: Biotechitalia
Figure 11.7 DELT Analysis: Sinclair Pharma
Figure 11.8 DELT Analysis: Merz Pharma
Figure 11.9 DELT Analysis: Dermosistemi
Figure 11.10 DELT Analysis: Alma Lasers
Figure 11.11 DELT Analysis: Bison Medical
Figure 11.12 DELT Analysis: Concluding Remarks
Figure 12.1 Market Drivers
Figure 12.2 Market Restraints
Figure 12.3 Market Opportunities
Figure 12.4 Market Challenges
Figure 13.1 Global Medical Aesthetics Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 13.2 Global Medical Aesthetics Market, 2023-2035: Conservative Scenario (USD Million)
Figure 13.3 Global Medical Aesthetics Market, 2023-2035: Optimistic Scenario (USD Million)
Figure 13.4 Dynamic Dashboard
Figure 14.1 Medical Aesthetics Market: Distribution by Type of Product and / or Device Offered, 2018, 2023 and 2035 (USD Million)
Figure 14.2 Medical Aesthetics Market for Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.3 Medical Aesthetics Market for Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.4 Medical Aesthetics Market for Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.5 Medical Aesthetics Market for Body Contouring: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.6 Medical Aesthetics Market for Hair Removal: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.7 Medical Aesthetics Market for Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.8 Medical Aesthetics Market for Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 14.9 Medical Aesthetics Market for Other Products and / or Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 15.1 Medical Aesthetics Market: Distribution by Type of Procedure, 2018, 2023 and 2035 (USD Million)
Figure 15.2 Medical Aesthetics Market for Non-invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 15.3 Medical Aesthetics Market for Minimally Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 15.4 Medical Aesthetics Market for Invasive Procedures: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.1 Medical Aesthetics Market: Distribution by End-user, 2018, 2023 and 2035 (USD Million)
Figure 16.2 Medical Aesthetics Market for Hospitals: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.3 Medical Aesthetics Market for Clinics / Med Spas and Dermatology / Cosmetology Centers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 16.4 Medical Aesthetics Market for Other End-users: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.1 Medical Aesthetics Market: by Distribution Channel, 2018, 2023 and 2035 (USD Million)
Figure 17.2 Medical Aesthetics Market for Direct Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 17.3 Medical Aesthetics Market for Indirect Distribution: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 18.1 Medical Aesthetics Market: Distribution by Gender, 2018, 2023 and 2035 (USD Million)
Figure 18.2 Medical Aesthetics Market for Females: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 18.3 Medical Aesthetics Market for Males: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.1 Medical Aesthetics Market: Distribution by Key Geographical Regions, 2019, 2023 and 2035 (USD Million)
Figure 19.2 Medical Aesthetics Market in North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.3 Medical Aesthetics Market in US: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.4 Medical Aesthetics Market in Canada: Historical Trends (2019 2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.5 Medical Aesthetics Market in Mexico: Historical Trends (2019 2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.6 Medical Aesthetics Market in Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.7 Medical Aesthetics Market in UK: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.8 Medical Aesthetics Market in Germany: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.9 Medical Aesthetics Market in France: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.10 Medical Aesthetics Market in Italy: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.11 Medical Aesthetics Market in Spain: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.12 Medical Aesthetics Market in Rest of the Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.13 Medical Aesthetics Market in Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.14 Medical Aesthetics Market in China: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.15 Medical Aesthetics Market in South Korea: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.16 Medical Aesthetics Market in Japan: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.17 Medical Aesthetics Market in India: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.19 Medical Aesthetics Market in Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.19 Medical Aesthetics Market in Turkey: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.20 Medical Aesthetics Market in Iran: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.21 Medical Aesthetics Market in Rest of the Middle East and North Africa: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.22 Medical Aesthetics Market in Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.23 Medical Aesthetics Market in Brazil: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.24 Medical Aesthetics Market in Argentina: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 19.25 Medical Aesthetics Market in Rest of the Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.1 Global Medical Aesthetics Products Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.2 Medical Aesthetics Products Market: Distribution by Type of Product Offered, 2018, 2023 and 2035 (USD Million)
Figure 20.3 Medical Aesthetics Products Market for Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.4 Medical Aesthetics Products Market for Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.5 Medical Aesthetics Products Market for Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.6 Medical Aesthetics Products Market for Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.7 Medical Aesthetics Products Market for Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.8 Medical Aesthetics Products Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035 (USD Million)
Figure 20.9 Medical Aesthetics Products Market in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.10 Medical Aesthetics Products Market in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.11 Medical Aesthetics Products Market in Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.12 Medical Aesthetics Products Market in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 20.13 Medical Aesthetics Products Market in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Figure 21.1 Conclusion: Market Landscape
Figure 21.2 Conclusion: Partnerships and Collaborations
Figure 21.3 Conclusion: Funding and Investments
Figure 21.4 Conclusion: Market Forecast and Opportunity Analysis

List Of Tables

Table 6.1 Medical Aesthetic Companies: Information on Year of Establishment, Company Size and Location of Headquarters
Table 6.2 Medical Aesthetic Companies: Information on Type of Offering
Table 6.3 Medical Aesthetic Companies: Information on Type of Products and / or Devices Offered
Table 6.4 Medical Aesthetic Companies: Information on Type of Facial Aesthetic Products and / or Devices Offered
Table 6.5 Medical Aesthetic Companies: Information on Type of Body Contouring Products and / or Devices, Hair Removal Devices and Breast Aesthetic Products and / or Devices Offered
Table 6.6 Medical Aesthetic Companies: Information on Application Area
Table 6.7 Medical Aesthetic Companies: Information on Type of Procedure and End-user
Table 7.1 Medical Aesthetics: List of Profiled Companies
Table 7.2 Allergan Aesthetics: Company Overview
Table 7.3 Allergan Aesthetics: Medical Aesthetics Portfolio
Table 7.4 Allergan Aesthetics: Recent Developments and Future Outlook
Table 7.5 Candela: Company Overview
Table 7.6 Candela: Medical Aesthetics Portfolio
Table 7.7 Cynosure: Company Overview
Table 7.8 Cynosure: Medical Aesthetics Portfolio
Table 7.9 Cynosure: Recent Developments and Future Outlook
Table 7.10 Lutronic: Company Overview
Table 7.11 Lutronic: Medical Aesthetics Portfolio
Table 7.12 Lutronic: Recent Developments and Future Outlook
Table 7.13 Mentor: Company Overview
Table 7.14 Mentor: Medical Aesthetics Portfolio
Table 7.15 BTL Aesthetics: Company Overview
Table 7.16 BTL Aesthetics: Medical Aesthetics Portfolio
Table 7.17 BTL Aesthetics: Recent Developments and Future Outlook
Table 7.18 Croma Pharma: Company Overview
Table 7.19 Croma Pharma: Medical Aesthetics Portfolio
Table 7.20 Croma Pharma: Recent Developments and Future Outlook
Table 7.21 Galderma: Company Overview
Table 7.22 Galderma: Medical Aesthetics Portfolio
Table 7.23 Galderma: Recent Developments and Future Outlook
Table 7.24 IBSA: Company Overview
Table 7.25 IBSA: Medical Aesthetics Portfolio
Table 7.26 IBSA: Recent Developments and Future Outlook
Table 7.27 Sinclair: Company Overview
Table 7.28 Sinclair: Medical Aesthetics Portfolio
Table 7.29 Sinclair: Recent Developments and Future Outlook
Table 7.30 Classys: Company Overview
Table 7.31 Classys: Medical Aesthetics Portfolio
Table 7.32 Classys: Recent Developments and Future Outlook
Table 7.33 Daeyang Medical: Company Overview
Table 7.34 Daeyang Medical: Medical Aesthetics Portfolio
Table 7.35 Establishment Labs: Company Overview
Table 7.36 Establishment Labs: Medical Aesthetics Portfolio
Table 7.37 Establishment Labs: Recent Developments and Future Outlook
Table 7.38 Lumenis: Company Overview
Table 7.39 Lumenis: Medical Aesthetics Portfolio
Table 7.40 Shanghai Haohai Biological Technology: Company Overview
Table 7.41 Shanghai Haohai Biological Technology: Medical Aesthetics Portfolio
Table 7.42 ADSS: Company Overview
Table 7.43 ADSS: Medical Aesthetics Portfolio
Table 7.44 Astiland: Company Overview
Table 7.45 Astiland: Medical Aesthetics Portfolio
Table 7.46 Beijing Kes Biological Technology: Company Overview
Table 7.47 Beijing Kes Biological Technology: Medical Aesthetics Portfolio
Table 7.48 Guangzhou Itech Aesthetics: Company Overview
Table 7.49 Guangzhou Itech Aesthetics: Medical Aesthetics Portfolio
Table 7.50 MedicalZone: Company Overview
Table 7.51 MedicalZone: Medical Aesthetics Portfolio
Table 7.52 Sanhe Medical: Company Overview
Table 7.53 Sanhe Medical: Medical Aesthetics Portfolio
Table 7.54 Sincoheren: Company Overview
Table 7.55 Sincoheren: Medical Aesthetics Portfolio
Table 7.56 Skin Tech Pharma: Company Overview
Table 7.57 Skin Tech Pharma: Medical Aesthetics Portfolio
Table 7.58 Wontech: Company Overview
Table 7.59 Wontech: Medical Aesthetics Portfolio
Table 7.60 Zesay Beauty: Company Overview
Table 7.61 Zesay Beauty: Medical Aesthetics Portfolio
Table 9.1 Medical Aesthetics: List of Partnerships and Collaborations
Table 9.2 Partnerships and Collaborations: Information on Location of Headquarters (Country and Region) and Type of Agreement (Country and Region)
Table 10.1 Medical Aesthetics: List of Funding and Investments
Table 11.1 Medical Aesthetics: Impact of Internal and External Factors on Key Players
Table 21.1 Medical Aesthetic Companies: Distribution by Year of Establishment
Table 21.2 Medical Aesthetic Companies: Distribution by Company Size
Table 21.3 Medical Aesthetic Companies: Distribution by Location of Headquarters (Region)
Table 21.4 Medical Aesthetic Companies: Distribution by Location of Headquarters (Country)
Table 21.5 Medical Aesthetic Companies: Distribution by Year of Establishment and Location of Headquarters (Region)
Table 21.6 Medical Aesthetic Companies: Distribution by Company Size and Location of Headquarters (Region)
Table 21.7 Medical Aesthetic Companies: Distribution by Type of Offering
Table 21.8 Medical Aesthetic Companies: Distribution by Type of Products and / or Devices Offered
Table 21.9 Medical Aesthetic Companies: Distribution by Type of Facial Aesthetic Products and / or Devices Offered
Table 21.10 Medical Aesthetic Companies: Distribution by Type of Body Contouring Products and / or Devices Offered
Table 21.11 Medical Aesthetic Companies: Distribution by Type of Hair Removal Devices Offered
Table 21.12 Medical Aesthetic Companies: Distribution by Type of Breast Aesthetic Products and / or Devices Offered
Table 21.13 Medical Aesthetic Companies: Distribution by Application Area
Table 21.14 Medical Aesthetic Companies: Distribution by Type of Procedure
Table 21.15 Medical Aesthetic Companies: Distribution by End-user
Table 21.16 Medical Aesthetic Companies: Distribution by Type of Products and / or Devices Offered and Location of Headquarters (Region)
Table 21.17 Medical Aesthetic Companies: Distribution by Type of Procedure and Location of Headquarters (Region)
Table 21.18 Allergan Aesthetics: Annual Revenues, FY 2020-H1 FY 2023 (USD Billion)
Table 21.19 Croma Pharma: Annual Revenues, FY 2021-FY 2022 (EUR Million)
Table 21.20 Galderma: Annual Revenues, FY 2020- H1 FY 2023 (USD Billion)
Table 21.21 Classys: Annual Revenues, FY 2020- H1 FY 2023 (KRW Million)
Table 21.22 Establishment Labs: Annual Revenues, FY 2019-FY H1 2023 (USD Million)
Table 21.23 Shanghai Haohai Biological Technology: Annual Revenues, FY 2019- H1 FY 2023 (RMB Million)
Table 21.24 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2023
Table 21.25 Partnerships and Collaborations: Distribution by Type of Partnership
Table 21.26 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2018-2023
Table 21.27 Partnerships and Collaborations: Distribution by Focus Area
Table 21.28 Most Active Players: Distribution by Number of Partnerships
Table 21.29 Partnerships and Collaborations: Local and International Agreements
Table 21.30 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 21.31 Funding and Investments: Cumulative Year-wise Trend, 2018-2023
Table 21.32 Funding and Investments: Distribution by Type of Funding
Table 21.33 Funding and Investments: Distribution by Amount Invested (USD Million)
Table 21.34 Funding and Investments: Distribution by Year and Type of Funding, 2018-2023
Table 21.35 Funding and Investments: Distribution by Type of Funding and Amount Invested (USD Million)
Table 21.36 Funding and Investments: Distribution by Geography (Region)
Table 21.37 Funding and Investments: Distribution by Geography (Country)
Table 21.38 Most Active Players: Distribution by Number of Funding Instances
Table 21.39 Most Active Players: Distribution by Amount Raised (USD Million)
Table 21.40 Leading Investors: Distribution by Number of Funding Instances
Table 21.41 Funding and Investments: Distribution by Company Size and Amount Invested
Table 21.42 Funding and Investments Summary, 2018-2023 (USD Million)
Table 21.43 Global Medical Aesthetics Market, 2018-2022 (USD Million)
Table 21.44 Global Medical Aesthetics Market, 2023-2035 (USD Million)
Table 21.45 Global Medical Aesthetics Market, 2023-2035: Conservative Scenario (USD Million)
Table 21.46 Global Medical Aesthetics Market, 2023-2035: Optimistic Scenario (USD Million)
Table 21.47 Medical Aesthetics Market: Distribution by Type of Product and / or Device Offered, 2018, 2023 and 2035 (USD Million)
Table 21.48 Medical Aesthetics Market for Botox, 2018-2022 (USD Million)
Table 21.49 Medical Aesthetics Market for Botox, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.50 Medical Aesthetics Market for Dermal Fillers, 2018-2022 (USD Million)
Table 21.51 Medical Aesthetics Market for Dermal Fillers, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.52 Medical Aesthetics Market for Chemical Peels, 2018-2022 (USD Million)
Table 21.53 Medical Aesthetics Market for Chemical Peels, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.54 Medical Aesthetics Market for Body Contouring, 2018-2022 (USD Million)
Table 21.55 Medical Aesthetics Market for Body Contouring, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.56 Medical Aesthetics Market for Hair Removal, 2018-2022 (USD Million)
Table 21.57 Medical Aesthetics Market for Hair Removal, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.58 Medical Aesthetics Market for Breast Implants, 2018-2022 (USD Million)
Table 21.59 Medical Aesthetics Market for Breast Implants, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.60 Medical Aesthetics Market for Gluteal Implants, 2018-2022 (USD Million)
Table 21.61 Medical Aesthetics Market for Gluteal Implants, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.62 Medical Aesthetics Market for Other Products and / or Devices, 2018-2022 (USD Million)
Table 21.63 Medical Aesthetics Market for Other Products and / or Devices, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.64 Medical Aesthetics Market: Distribution by Type of Procedure, 2018, 2023 and 2035 (USD Million)
Table 21.65 Medical Aesthetics Market for Non-invasive Procedures, Conservative, 2018-2022 (USD Million)
Table 21.66 Medical Aesthetics Market for Non-invasive Procedures, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.67 Medical Aesthetics Market for Minimally Invasive Procedures, 2018-2022 (USD Million)
Table 21.68 Medical Aesthetics Market for Minimally Invasive Procedures, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.69 Medical Aesthetics Market for Invasive Procedures, 2018-2022 (USD Million)
Table 21.70 Medical Aesthetics Market for Invasive Procedures, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.71 Medical Aesthetics Market: Distribution by End-user, 2018, 2023 and 2035 (USD Million)
Table 21.72 Medical Aesthetics Market for Hospitals, 2018-2022 (USD Million)
Table 21.73 Medical Aesthetics Market for Hospitals, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.74 Medical Aesthetics Market for Clinics / Med Spas and Dermatology / Cosmetology Centers, 2018-2022 (USD Million)
Table 21.75 Medical Aesthetics Market for Clinics / Med Spas and Dermatology / Cosmetology Centers, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.76 Medical Aesthetics Market for Other End-users, 2018-2022 (USD Million)
Table 21.77 Medical Aesthetics Market for Other End-users, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.78 Medical Aesthetics Market: by Distribution Channel, 2018, 2023 and 2035 (USD Million)
Table 21.79 Medical Aesthetics Market for Direct Distribution, 2018-2022 (USD Million)
Table 21.80 Medical Aesthetics Market for Direct Distribution, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.81 Medical Aesthetics Market for Indirect Distribution, 2018-2022 (USD Million)
Table 21.82 Medical Aesthetics Market for Indirect Distribution, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.83 Medical Aesthetics Market: Distribution by Gender, 2018, 2023 and 2035 (USD Million)
Table 21.84 Medical Aesthetics Market for Males, Conservative, 2018-2022 (USD Million)
Table 21.85 Medical Aesthetics Market for Males, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.86 Medical Aesthetics Market for Females, 2018-2022 (USD Million)
Table 21.87 Medical Aesthetics Market for Females, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.88 Medical Aesthetics Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035 (USD Million)
Table 21.89 Medical Aesthetics Market in North America, 2018-2022 (USD Million)
Table 21.90 Medical Aesthetics Market in North America, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.91 Medical Aesthetics Market in US, 2018-2022 (USD Million)
Table 21.92 Medical Aesthetics Market in US, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.93 Medical Aesthetics Market in Canada, 2018-2022 (USD Million)
Table 21.94 Medical Aesthetics Market in Canada, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.95 Medical Aesthetics Market in Mexico, 2018-2022 (USD Million)
Table 21.96 Medical Aesthetics Market in Mexico, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.97 Medical Aesthetics Market in Europe, 2018-2022 (USD Million)
Table 21.98 Medical Aesthetics Market in Europe, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.99 Medical Aesthetics Market in UK, 2018-2022 (USD Million)
Table 21.100 Medical Aesthetics Market in UK, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.101 Medical Aesthetics Market in Germany, 2018-2022 (USD Million)
Table 21.102 Medical Aesthetics Market in Germany, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.103 Medical Aesthetics Market in France, 2018-2022 (USD Million)
Table 21.104 Medical Aesthetics Market in France, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.105 Medical Aesthetics Market in Italy, 2018-2022 (USD Million)
Table 21.106 Medical Aesthetics Market in Italy, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.107 Medical Aesthetics Market in Spain, 2018-2022 (USD Million)
Table 21.108 Medical Aesthetics Market in Spain, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.109 Medical Aesthetics Market in Rest of the Europe, 2018-2022 (USD Million)
Table 21.110 Medical Aesthetics Market in Rest of the Europe, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.111 Medical Aesthetics Market in Asia-Pacific, 2018-2022 (USD Million)
Table 21.112 Medical Aesthetics Market in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.113 Medical Aesthetics Market in China, 2018-2022 (USD Million)
Table 21.114 Medical Aesthetics Market in China, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.115 Medical Aesthetics Market in South Korea, 2018-2022 (USD Million)
Table 21.116 Medical Aesthetics Market in South Korea, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.117 Medical Aesthetics Market in Japan, 2018-2022 (USD Million)
Table 21.118 Medical Aesthetics Market in Japan, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.119 Medical Aesthetics Market in India, 2018-2022 (USD Million)
Table 21.120 Medical Aesthetics Market in India, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.121 Medical Aesthetics Market in Middle East and North Africa, 2018-2022 (USD Million)
Table 21.122 Medical Aesthetics Market in Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.123 Medical Aesthetics Market in Turkey, 2018-2022 (USD Million)
Table 21.124 Medical Aesthetics Market in Turkey, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.125 Medical Aesthetics Market in Iran, 2018-2022 (USD Million)
Table 21.126 Medical Aesthetics Market in Iran, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.127 Medical Aesthetics Market in Rest of the Middle East and North Africa, 2018-2022 (USD Million)
Table 21.128 Medical Aesthetics Market in Rest of the Middle East and North Africa, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.129 Medical Aesthetics Market in Latin America, 2018-2022 (USD Million)
Table 21.130 Medical Aesthetics Market in Latin America, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.131 Medical Aesthetics Market in Brazil, 2018-2022 (USD Million)
Table 21.132 Medical Aesthetics Market in Brazil, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.133 Medical Aesthetics Market in Argentina, 2018-2022 (USD Million)
Table 21.134 Medical Aesthetics Market in Argentina, 2023-2035 (USD Million)
Table 21.135 Medical Aesthetics Market in Rest of the Latin America, 2018-2022 (USD Million)
Table 21.136 Medical Aesthetics Market in Rest of the Latin America, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 21.137 Global Medical Aesthetics Products Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.138 Medical Aesthetics Products Market: Distribution by Type of Product Offered 2023-2035 (USD Million)
Table 21.139 Medical Aesthetics Products Market for Botox: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.140 Medical Aesthetics Products Market for Dermal Fillers: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.141 Medical Aesthetics Products Market for Chemical Peels: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.142 Medical Aesthetics Products Market for Breast Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.143 Medical Aesthetics Products Market for Gluteal Implants: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.144 Medical Aesthetics Products Market : Distribution by Key Geographical Regions, 2018, 2023 and 2035 (USD Million)
Table 21.145 Medical Aesthetics Products Market in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.146 Medical Aesthetics Products Market in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.147 Medical Aesthetics Products Market in Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.148 Medical Aesthetics Products Market in Middle East and North Africa: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)
Table 21.149 Medical Aesthetics Products Market in Latin America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Million)

List Of Companies

  1. 3D Aesthetics
  2. 3D Systems
  3. AbbVie
  4. Abell Foundation
  5. Abu Dhabi Investment Authority
  6. ACROSS
  7. ADODERM
  8. ADSS
  9. Advalight
  10. Aeon Pharma
  11. Aerolase
  12. Aestura (a subsidiary of Amorepacific)
  13. AGNES MEDICAL
  14. ALASTIN Skincare
  15. Allergan Aesthetics 
  16. Alma Lasers
  17. Alpha aesthetics
  18. Alpha Investment
  19. Alsanza Medizintechnik und Pharma 
  20. Alteon
  21. AMI
  22. AMP
  23. AngelMD
  24. Anzu Partners
  25. APX Platform
  26. Apyx Medical
  27. Aquavit
  28. ARCH Venture Partners
  29. Asclepion 
  30. Astiland
  31. Athyrium Capital Management
  32. Australian Skin Clinics
  33. Avenue Venture Opportunities Fund
  34. Barak Capital Underwriters
  35. Beauty Aesthetic
  36. BeautyCom Biotechnology
  37. Beijing KES Biology Technology
  38. Beijing Sanhe Technology
  39. BENEV
  40. BES
  41. Beyond Medical Aesthetics
  42. Bimini Health Tec
  43. Biomatics Capital
  44. BioPlus
  45. Bioscience
  46. Biotech Italia
  47. Bioxis pharmaceuticals
  48. Bison Medical
  49. BNC Korea
  50. BPI
  51. BR Meditech
  52. Brera Medical Technologies
  53. BTL Aesthetics
  54. BVLaser
  55. Caliway Biopharmaceuticals
  56. Candela
  57. Canons Clinics
  58. Cartessa Aestherics
  59. CD&R
  60. CELLINK
  61. ChiMin Health Management
  62. ChungWoo
  63. Clairderm Medical Aesthetics
  64. Clarion Medical Technologies
  65. CLASSYS
  66. ClinicalPRO
  67. Clinipro
  68. Clinisept+
  69. CMed Aesthetics
  70. Cocoon Medical
  71. Cogmedix (a subsidiary of Coghlin Companies)
  72. CollPlant Biotechnologies
  73. Croma-Pharma
  74. Crown Aesthetics
  75. Crown Laboratories
  76. Cutera
  77. Cynosure
  78. Cypris Medical
  79. Cytophil
  80. Cytrellis Biosystems
  81. D1 Capital Partners
  82. Daeyang Medical
  83. Decomedical
  84. Deerfield Management 
  85. Deka Aesthetics 
  86. Deleo
  87. DermapenWorld
  88. Dermosistemi
  89. Dimed Laser
  90. Dominion Aesthetic Technologies
  91. Dongwha Pharm
  92. DTA Medical
  93. DubiMed
  94. E.S.I Novel
  95. Ecleris
  96. Eclipse Med
  97. EIC Accelerator
  98. Eirion Therapeutics
  99. ELESTA
  100. EMA Aesthetics
  101. EME
  102. Emerald Development Managers
  103. EMK Medical
  104. EmShape Korea
  105. ENDYMED
  106. EQT Partners
  107. Erchonia
  108. Establishment Labs
  109. Etoile
  110. Evolus
  111. EW Healthcare Partners
  112. ExoCoBio
  113. F Care Systems
  114. FILLMED
  115. FineMEC
  116. Finovam Gestion
  117. Fisoline
  118. FONGIT Innovation Fund
  119. Formatk
  120. Fotona
  121. Funshine
  122. Galderma
  123. Gale Force Aesthetics
  124. GC Aesthetics
  125. Genesis Biosystems
  126. GIGAALASER
  127. German Medical Engineering
  128. GPQ Srl
  129. Shenzen GSD Tech
  130. ASPIOON 
  131. Guangzhou iTech Aesthetics
  132. Guangzhou zesaybeauty
  133. HAEMATO
  134. Hahn & Company
  135. Harley Technologies
  136. Harrods
  137. Hayfin Capital Management
  138. HealthQuest Capital
  139. Hildred Capital Partners
  140. Hironic
  141. HTDK
  142. HTL
  143. Huadong Medicine
  144. Hugel Aesthetics
  145. Huons BioPharma
  146. Huons Meditech
  147. HYALURONICA
  148. IBSA
  149. IDEAL IMPLANT
  150. INDIBA
  151. InMode
  152. Innooaesthetics
  153. invisa-RED
  154. Iskra Medical
  155. Jeisys Medical
  156. Jetema
  157. JUVA
  158. Kairos Venture Investments
  159. Koru Pharma
  160. KYLANE LABORATOIRES
  161. KYLYS
  162. Laser Lipo
  163. Laserconn
  164. LASEROPTEK
  165. LasMedTech
  166. Lattice Medical
  167. LAYUN KOREA
  168. Leaflife
  169. LED SpA
  170. Ledsmedical
  171. Legolaser
  172. LifeSprout
  173. LINLINE Medical Systems
  174. Love Cosmedical
  175. LP Aesthetics
  176. Lumenis
  177. Luminera
  178. LumiSKN
  179. Luna Clinic
  180. Lutronic
  181. LUVO Medical
  182. Lynton Surgical
  183. M&T Srl
  184. MagnaSci Ventures
  185. Mantis Srl
  186. Mastelli
  187. Masters Special Situations
  188. Maya Beauty Engineering (MBE)
  189. McNAIR
  190. MECA
  191. MedArt Technology
  192. MedicalZone
  193. Mediserve
  194. MedTech Lasers
  195. Medytox
  196. Mentor 
  197. Merz Pharma
  198. mesoestetic
  199. Mesotech Srl
  200. Meyer-Haake
  201. MicroAire
  202. MidCap Financial
  203. milesman
  204. Monarch Laser Services
  205. Montreux Growth Partners
  206. Morton Cohn Investments
  207. Powered by MRP
  208. My Med Aesthetics
  209. MyEllevate
  210. Natieco
  211. National Futures Association
  212. National Ultrasound
  213. Neauvia
  214. NEDAL
  215. NEOconcepts
  216. NeoGenesis
  217. NewBeauty
  218. Newpong
  219. Nexus Management
  220. NGH Aesthetics
  221. NIUU Medical Aesthetics
  222. Nord France Amorçage
  223. Nova Medical
  224. Nova Threads
  225. NovaVision
  226. Novoxel
  227. Noxogen Therapeutics
  228. NYUMA PHARMA
  229. Oaktree Capital Management
  230. Oxford Finance
  231. Oyster Capital Partners
  232. PB&B
  233. PFM Health Sciences
  234. Phanes Beauty
  235. Pharmaesthetics
  236. Pharmakon Advisors
  237. PharmaResearch
  238. PhaseTech
  239. PhotoMedex
  240. Pollogen
  241. POLYTECH Health & Aesthetics
  242. Priveterra
  243. Pro 1 Laser
  244. ProCell Therapeutics
  245. Professional Dietetics
  246. Prollenium Medical Technologies
  247. Promoitalia
  248. Hakomed Italia
  249. Quanta System
  250. Qventis
  251. Redmile
  252. REGENBOGEN
  253. Restoration Robotics
  254. Revance Therapeutics
  255. Reveal Lasers
  256. Revelle Aesthetics
  257. Robosculptor
  258. Rohrer Aesthetics
  259. Sands Capital
  260. Santelys
  261. Sapphire Aesthetics
  262. Sciton
  263. SciVision Biotech
  264. Seishin Plastic and Aesthetic Surgery Clinic
  265. Shanghai Apolo Medical Technology
  266. Shanghai Fosun Pharmaceutical
  267. Shanghai Haohai Biological Technology
  268. SharpLight Technologies
  269. Sientra
  270. SILK Laser Clinics
  271. Silk Medical Aesthetics
  272. Sinclair Pharma
  273. Sincoheren
  274. Skin Tech Pharma
  275. Smedtrum
  276. SNJ
  277. Sofregen
  278. Softwave Medical
  279. Soliton
  280. Solta Medical 
  281. Stratasys
  282. Suisselle
  283. Suneva Medical
  284. Symatese
  285. Synergy 
  286. TavTech
  287. TEDCO
  288. Tema Medicina
  289. Teoxane
  290. The Perfect Peel
  291. TriCell Aesthetics
  292. Trinity Capital
  293. Triskelion Investments
  294. TRIWORKS
  295. UMECO
  296. Union Medical
  297. Venus Concept

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more about Department License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com